ES Biodesign Consulting has announced plans to develop a new AI-powered software tool aimed at helping medical device companies detect potential equity and compliance issues in their designs before submission to the U.S. Food and Drug Administration. The tool will analyze design documents for gaps that could affect regulatory approval and patient access, an extension […]

Only subscribers get to read this.

Hit SUBSCRIBE for freemium or paid content access.